Michael Lachman

Michael Lachman

Contributing Writer

Michael Lachman is President of EyeQ Research, which provides market research, analytics, and strategic advisory to ophthalmic companies and investors. Previously, he was a healthcare investment research analyst with Hambrecht & Quist, ThinkEquity Partners, and SAC Capital, and worked in business development, marketing, and R&D for Johnson & Johnson and Baxter.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma

September 1 2020

OIS Index Lags Again in August

The OIS Index of ophthalmic stocks declined 0.4% in August, underperforming its benchmark indices for the second straight month. The NASDAQ Biotechnology Index posted a ...
Read More
OIS Index Q2

July 9 2020

OIS Index Rallies Back from COVID-Driven Decline

The OIS Index of ophthalmic stocks staged a strong comeback in Q2, gaining 21.4%, in line with the overall US stock market as measured by ...
Read More
OIS-Index

June 3 2020

May Extends April’s Rebound from March Lows

The OIS Index of ophthalmic stocks gained 7.9% in May, following a 12.2% gain in April, extending the rebound from the mid-March lows. Over the ...
Read More
OIS Index 5.14.2020

May 14 2020

OIS Index Rebounds from March Lows

The OIS Index of ophthalmic stocks gained 12.2% in April, participating in the market rebound from the mid-March lows that led to the best month ...
Read More
OIS Index: No Immunity to Coronavirus Selloff

April 8 2020

OIS Index: No Immunity to Coronavirus Selloff

The OIS Index of ophthalmic stocks followed global stock markets into bear market territory in Q1, declining 21.2%, in line with the overall US stock ...
Read More
OIS Index Down in February

March 3 2020

OIS Index Down in February

The OIS Index of ophthalmic stocks declined 9.6% in February, tracking the declines for medical device stocks (-8.7%) and the broader US stock market (-8.4%), ...
Read More
OIS Index

February 5 2020

OIS Index Gained 2%+ in Jan

The OIS Index of ophthalmic stocks gained 2.1% in January, outperforming medical device stocks (+0.1%), the biotech sector (-5.6%%), and the broader US stock market ...
Read More
OIS Index Posts a Strong Finish to 2019

January 9 2020

OIS Index Posts a Strong Finish to 2019

The OIS Index of ophthalmic stocks made a strong comeback in Q4-2019, following a rough Q3. The index gained 16.2% in Q4, slightly underperforming the ...
Read More
OIS Index Outperforms

December 4 2019

OIS Index Outperforms

The OIS Index of ophthalmic stocks gained 5.4% in November, following a similar 5.2% gain in October. The index outperformed medical device stocks (+4.3%) and ...
Read More
OIS Index Nov. 2019

November 6 2019

OIS Index on Positive Upswing

The OIS Index of ophthalmic stocks gained 5.2% in October, posting its first month of positive performance since June. The index lagged the biotech sector ...
Read More
OIS Index Deep in Bear Territory in Q3

October 2 2019

OIS Index Deep in Bear Territory in Q3

The OIS Index of ophthalmic stocks posted a miserable Q3 performance, led by the biopharmaceutical stocks in the index. The OIS Index (-12.0%) underperformed the ...
Read More
OIS Index Q2 2019

July 10 2019

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

The OIS Index of ophthalmic stocks posted a modest positive return of +0.8% during the second quarter of 2019. The index outperformed the NASDAQ Biotechnology ...
Read More